Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insulin receptor beta subunit is a transmembrane protein that is part of the insulin receptor complex. It possesses intrinsic tyrosine kinase activity and is essential for mediating insulin's effects on glucose homeostasis and metabolism. Upon insulin binding to the alpha subunit, the beta subunit undergoes autophosphorylation, initiating downstream signaling cascades that regulate glucose uptake, glycogen synthesis, and other metabolic processes. Dysfunction or mutations in the beta subunit can contribute to diseases like diabetes mellitus and cancer.
Activation of intracellular signaling pathways through tyrosine kinase activity and phosphorylation of downstream substrates like IRS proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Receptor Beta Subunit (INSR Beta).